The Latest Cardiac and Vascular News
New data shows Clario has helped more than 2.6 million patients participate in life changing clinical trials for innovative new medicines through decentralized and hybrid technology solutions More than 1000 compounds: Number of potential medicines tested using Clario remote data collection technologies Over 2.6 million patients: Number of participants in Clario DCTs […]
2022 Q3 quarterly HIGHLIGHTS compared to the corresponding period of 2021: Revenue was $14.0 million, same as the prior year period Net income was $3.7 million, or $0.55 per basic share and $0.46 per diluted share, compared to $4.2 million, or $0.61 per basic share and $0.51 per diluted share Cash and cash equivalents at September 30, 2022 increased to $45.5 million from $35.9 million SANTA CLARA, […]
COPENHAGEN, Denmark, Nov. 2, 2022 /PRNewswire/ — The grant will enable leading international researchers to complete a clinical trial comparing the two most common treatment methods for preventing leg amputation among people with critical limb ischaemia. Critical limb ischaemia is a serious and debilitating disease that affects about 22 million people globally, […]
SHANGHAI, Nov. 2, 2022 /PRNewswire/ — Shanghai Operation Robot Co.,Ltd announced the results of its initial clinical trial of ERCP (Endoscopic retrograde cholangiopancreatography) robot in biliary stent placement surgery. It is the first Robot-assisted human clinical trial of biliary stent placement surgery in the world. The surgery was conducted by Aopeng Medical. The […]
DENVER, Nov. 1, 2022 /PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY) (the “Company”) today announced financial results for the third quarter ended September 30, 2022. Third Quarter 2022 Highlights Total revenue for the third quarter 2022 was approximately $26.5 million, primarily from four revenue units, compared to approximately $19.2 million, primarily from three revenue units, in the third […]
CARLSBAD, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on November 1, 2022 that were approved by the Compensation Committee of its Board of […]
Third quarter 2022 revenue of $6.2 million, an 82% increase over prior year MINNEAPOLIS, Nov. 01, 2022 (GLOBE NEWSWIRE) — CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for […]
SAN FRANCISCO, Nov. 01, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today reported financial results for the three months ended September 30, 2022. Third Quarter 2022 Financial Results Revenue of $103.9 million, a 21.6% […]
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on October 31, 2022 it granted stock options to purchase an aggregate of 202,500 shares of common stock to 20 new employees, whose employment commenced in October 2022, as a material inducement to […]
Eric Adler, M.D., joins LEXEO as Chief Scientific Officer New Scientific Advisory Board comprised of molecular cardiology, cardiovascular imaging, cardiac gene-editing, and RNA biology experts NEW YORK, Nov. 02, 2022 (GLOBE NEWSWIRE) — LEXEO Therapeutics, Inc. (LEXEO), a clinical-stage biotech company advancing a pipeline of adeno-associated virus (AAV)-based gene therapy candidates […]
